Recursion Pharmaceuticals
RXRX
RXRX
334 hedge funds and large institutions have $1.03B invested in Recursion Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 61 funds opening new positions, 132 increasing their positions, 81 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
1% more funds holding
Funds holding: 332 → 334 (+2)
22% less capital invested
Capital invested by funds: $1.33B → $1.03B (-$294M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
334
Holding in Top 10
3
Calls
$17.9M
Puts
$10.9M
Top Buyers
| 1 | +$16.7M | |
| 2 | +$14.9M | |
| 3 | +$12.2M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$11.2M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$10.2M |
Top Sellers
| 1 | -$13.9M | |
| 2 | -$13.4M | |
| 3 | -$9.68M | |
| 4 |
Barclays
London,
United Kingdom
|
-$5.09M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$3.59M |
